Restricted Mean Survival Time for Analysis and Interpretation of Clinical Trials for Heart Failure Devices

被引：0
|
作者：
Perego, Carlotta [1 ]
Sbolli, Marco [1 ]
Specchia, Claudia [2 ]
Oriecuia, Chiara [2 ]
Peveri, Giulia [3 ]
Fiuzat, Mona [4 ]
O'Connor, Christopher [1 ]
Metra, Marco [2 ]
Wei, Lee-Jen [5 ]
Psotka, Mitchell [1 ]
机构：
[1] Inova Heart & Vasc Inst, Falls Church, VA USA
[2] Univ Brescia, Brescia, Italy
[3] Univ Milan, Milan, Italy
[4] Duke Univ, Durham, NC USA
[5] Harvard Univ, Boston, MA 02115 USA
来源：
JOURNAL OF CARDIAC FAILURE | 2020年 / 26卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
179
引用
收藏
页码：S64 / S64
页数：1
相关论文
共 50 条
  • [21] EFFECT OF ADULT CONGENITAL HEART DISEASE STATUS ON LONG-TERM SURVIVAL AFTER HEART TRANSPLANTATION: A RESTRICTED MEAN SURVIVAL TIME ANALYSIS
    Dolgner, Stephen
    Nguyen, Vidang P.
    Dardas, Todd
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 568 - 568
  • [22] Dynamic prediction and analysis based on restricted mean survival time in survival analysis with nonproportional hazards
    Yang, Zijing
    Wu, Hongji
    Hou, Yawen
    Yuan, Hao
    Chen, Zheng
    [J]. Computer Methods and Programs in Biomedicine, 2021, 207
  • [23] Dynamic prediction and analysis based on restricted mean survival time in survival analysis with nonproportional hazards
    Yang, Zijing
    Wu, Hongji
    Hou, Yawen
    Yuan, Hao
    Chen, Zheng
    [J]. COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE, 2021, 207
  • [24] Restricted mean survival time as a function of restriction time
    Zhong, Yingchao
    Schaubel, Douglas E.
    [J]. BIOMETRICS, 2022, 78 (01) : 192 - 201
  • [25] Analysis of restricted mean survival time for length-biased data
    Lee, Chi Hyun
    Ning, Jing
    Shen, Yu
    [J]. BIOMETRICS, 2018, 74 (02) : 575 - 583
  • [26] Clustered restricted mean survival time regression
    Chen, Xinyuan
    Harhay, Michael O.
    Li, Fan
    [J]. BIOMETRICAL JOURNAL, 2023, 65 (06)
  • [27] First-line treatments for chronic lymphocytic leukemia: Analysis of 7 trials based on the restricted mean survival time
    Bartoli, Laura
    Ferracane, Elisa
    Trippoli, Sabrina
    Messori, Andrea
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2021, 59 (04) : 322 - 327
  • [28] The use of restricted mean survival time to estimate the treatment effect in randomized clinical trials when the proportional hazards assumption is in doubt
    Royston, Patrick
    Parmar, Mahesh K. B.
    [J]. STATISTICS IN MEDICINE, 2011, 30 (19) : 2409 - 2421
  • [29] Why restricted mean survival time methods are especially useful for non-inferiority trials
    Quartagno, Matteo
    Morris, Tim P.
    White, Ian R.
    [J]. CLINICAL TRIALS, 2021, 18 (06) : 743 - 745
  • [30] Treatment effects measured by restricted mean survival time in trials of immune checkpoint inhibitors for cancer
    Liang, F.
    Zhang, S.
    Wang, Q.
    Li, W.
    [J]. ANNALS OF ONCOLOGY, 2018, 29 (05) : 1320 - 1324
12345